Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : BNTX exchanges : Nasdaq save search
Understanding the mRNA Therapeutics Market's -8.6% Decline: Insights from BCC Research
Published: 2024-04-10 (Crawled : 14:30) - prnewswire.com
OMGA | $2.42 93K
|
|
| O: -0.33%
H: 0.17%
C: 0.0%
CVAC | News | $2.41 -1.23% 190K
|
Health Technology
|
| O: -0.67%
H: 1.36%
C: 0.0%
BNTX | $86.81 0.74% 230K
|
Health Technology
|
| O: -1.69%
H: 0.97%
C: 0.14%
mrna research therapeutics
Three-year Phase 1 Follow-Up Data for mRNA-based Individualized Immunotherapy Candidate Show Persistence of Immune Response and Delayed Tumor Recurrence in Some Patients with Resected Pancreatic Cancer
Published: 2024-04-07 (Crawled : 20:20) - globenewswire.com
BNTX | $86.81 0.74% 230K
|
Health Technology
|
| O: 1.38%
H: 0.2%
C: -1.27%
candidate cancer pancreatic tumor immunotherapy for response show
Matinas BioPharma Reports 2023 Financial Results and Provides a Business Update
Published: 2024-03-27 (Crawled : 20:00) - globenewswire.com
BNTX | $86.81 0.74% 230K
|
Health Technology
|
| O: -0.08%
H: 1.01%
C: -0.7%
MTNB | $0.1913 0.68% 190K
|
Health Technology
|
| O: -3.38%
H: 2.32%
C: -3.25%
business update biopharma financial results
BioNTech Announces Fourth Quarter and Full Year 2023 Financial Results and Corporate Update
Published: 2024-03-20 (Crawled : 11:00) - biospace.com/
BNTX | $86.81 0.74% 230K
|
Health Technology
|
| O: -5.51%
H: 1.33%
C: 1.2%
AUTL | $4.73 -1.46% 99K
|
Health Technology
|
| O: 1.45%
H: 5.33%
C: 4.13%
year update financial results
BioNTech Announces Appointment of Annemarie Hanekamp to Management Board as Chief Commercial Officer
Published: 2024-03-20 (Crawled : 10:00) - globenewswire.com
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: -1.37%
H: 0.0%
C: -1.58%
NVS | $93.81 1.34% 1.2M
|
Health Technology
|
| O: -0.62%
H: 0.45%
C: 0.34%
BNTX | $86.81 0.74% 230K
|
Health Technology
|
| O: -5.51%
H: 1.33%
C: 1.2%
management commercial
Lipid-Nanoparticle Based Genomic Medicines Market worth $32.5 Bn by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd.
Published: 2024-03-18 (Crawled : 14:00) - prnewswire.com
CVAC | News | $2.41 -1.23% 190K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: -2.73%
BNTX | $86.81 0.74% 230K
|
Health Technology
|
| O: 0.48%
H: 1.18%
C: 0.08%
ABUS | News | $2.705 -0.92% 300K
|
Health Technology
|
| O: 0.38%
H: 0.38%
C: -3.42%
report genomic market
Autolus Therapeutics Reports Full Year 2023 Financial Results and Business Updates
Published: 2024-03-14 (Crawled : 11:00) - globenewswire.com
BNTX | $86.81 0.74% 230K
|
Health Technology
|
| O: 0.11%
H: 0.3%
C: -1.21%
AUTL | $4.73 -1.46% 99K
|
Health Technology
|
| O: 1.82%
H: 12.19%
C: 2.15%
business year therapeutics financial results
BNTX DEADLINE TODAY: ROSEN, SKILLED INVESTOR COUNSEL, Encourages BioNTech SE Investors to Secure Counsel Before Important March 12 Deadline in Securities Class Action - BNTX
Published: 2024-03-12 (Crawled : 19:00) - prnewswire.com
NARI S | $38.915 0.71% 99K
|
Health Technology
|
| O: -0.43%
H: 2.53%
C: -1.41%
BNTX | $86.81 0.74% 230K
|
Health Technology
|
| O: 0.01%
H: 0.98%
C: -1.87%
deadline
CMAX ALERT: Levi & Korsinsky, LLP Commences an Investigation of CareMax, Inc. (CMAX) f/k/a Deerfield Healthcare Technology Acquisitions Corp. (DFHT)
Published: 2024-03-12 (Crawled : 19:00) - prnewswire.com
CMAX | $2.7 12.5% 33K
|
Manufacturing
|
| O: -0.61%
H: 4.46%
C: -10.62%
BNTX | $86.81 0.74% 230K
|
Health Technology
|
| O: 0.01%
H: 0.98%
C: -1.87%
acquisitions technology
ALVR IMPORTANT DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages AlloVir, Inc. Investors to Secure Counsel Before Important March 19 Deadline in Securities Class Action - ALVR
Published: 2024-03-12 (Crawled : 19:00) - prnewswire.com
BNTX | $86.81 0.74% 230K
|
Health Technology
|
| O: 0.01%
H: 0.98%
C: -1.87%
ALVR | $0.75 1.07% 110K
|
Health Technology
|
| O: -0.14%
H: 1.49%
C: -1.43%
deadline global
CTXTQ ALERT: Levi & Korsinsky, LLP Commences an Investigation of Cyxtera Technologies, Inc. (CYXTQ) f/k/a Starboard Value Acquisition (SVAC)
Published: 2024-03-12 (Crawled : 19:00) - prnewswire.com
BNTX | $86.81 0.74% 230K
|
Health Technology
|
| O: 0.01%
H: 0.98%
C: -1.87%
acquisition
EAF INVESTOR NOTIFICATION: Kessler Topaz Meltzer & Check, LLP Announces Lead Plaintiff Deadline on March 25, 2024 in Securities Fraud Class Action Lawsuit Filed against GrafTech International Ltd.
Published: 2024-03-12 (Crawled : 01:00) - prnewswire.com
EAF | $1.515 2.37% 1.3M
|
Producer Manufacturing
|
| O: -0.56%
H: 8.38%
C: 4.47%
BNTX | $86.81 0.74% 230K
|
Health Technology
|
| O: 0.54%
H: 0.18%
C: -1.13%
international deadline
Kessler Topaz Meltzer & Check, LLP Investigates The Chemours Company for Potential Securities Violations and Encourages Investors to Contact Firm
Published: 2024-03-11 (Crawled : 23:00) - prnewswire.com
AMPL | $9.42 -0.42% 100K
|
|
| O: 0.27%
H: 0.54%
C: -0.63%
CC | $26.14 -1.28% 220K
|
Process Industries
|
| O: -0.34%
H: 1.38%
C: 0.27%
BNTX | $86.81 0.74% 230K
|
Health Technology
|
| O: 0.54%
H: 0.18%
C: -1.13%
company potential
BioNTech to Present Clinical Data Updates for Personalized mRNA-based and Targeted Oncology Candidates at AACR 2024
Published: 2024-03-11 (Crawled : 12:00) - globenewswire.com
BNTX | $86.81 0.74% 230K
|
Health Technology
|
| O: -0.19%
H: 7.03%
C: 5.71%
ADM Investors Have Opportunity to Lead Archer-Daniels-Midland Company Securities Fraud Lawsuit
Published: 2024-03-08 (Crawled : 16:00) - prnewswire.com
ADM | $62.565 1.37% 1.4M
|
Process Industries
|
| O: -0.07%
H: 1.9%
C: 1.11%
BROG | $1.15 3.6% 540K
|
Finance
|
| O: 5.66%
H: 6.59%
C: 6.59%
BNTX | $86.81 0.74% 230K
|
Health Technology
|
| O: 0.0%
H: 0.48%
C: 0.2%
company
BNTX Investors Have Opportunity to Lead BioNTech SE Securities Fraud Lawsuit
Published: 2024-03-08 (Crawled : 16:00) - prnewswire.com
BTAFF | $28.176 1.8K
|
Consumer Non-Durables
|
| O: 0.5%
H: 0.13%
C: -0.94%
BTI | $28.825 0.02% 2.7M
|
Consumer Non-Durables
|
| O: -0.07%
H: 0.58%
C: 0.44%
DADA | $1.875 1.9% 290K
|
Technology Services
|
| O: 1.63%
H: 0.58%
C: -7.6%
BNTX | $86.81 0.74% 230K
|
Health Technology
|
| O: 0.0%
H: 0.48%
C: 0.2%
Kessler Topaz Meltzer & Check, LLP Reminds BioNTech SE Investors of Important Deadline in Securities Fraud Class Action Lawsuit and Encourages Investors with Substantial Losses to Contact the Firm
Published: 2024-03-07 (Crawled : 22:00) - prnewswire.com
MBLY | $31.055 0.24% 510K
|
|
| O: 1.06%
H: 0.49%
C: -3.77%
AMPL | $9.42 -0.42% 100K
|
|
| O: 1.08%
H: 0.89%
C: -1.38%
BNTX | $86.81 0.74% 230K
|
Health Technology
|
| O: 0.0%
H: 0.48%
C: 0.2%
deadline
BioNTech Announces Planned Retirement of Sean Marett
Published: 2024-03-07 (Crawled : 12:00) - globenewswire.com
BNTX | $86.81 0.74% 230K
|
Health Technology
|
| O: 0.0%
H: 0.55%
C: -0.33%
Lost Money on BioNTech SE(BNTX)? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm
Published: 2024-03-07 (Crawled : 11:00) - prnewswire.com
AMLX | $1.96 -1.01% 430K
|
|
| O: -0.68%
H: 1.37%
C: 0.26%
INMD | $17.225 -0.66% 280K
|
Health Technology
|
| O: 0.88%
H: 0.52%
C: -1.26%
BNTX | $86.81 0.74% 230K
|
Health Technology
|
| O: 0.0%
H: 0.55%
C: -0.33%
BioNTech to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update on March 20, 2024
Published: 2024-03-06 (Crawled : 12:00) - globenewswire.com
BNTX | $86.81 0.74% 230K
|
Health Technology
|
| O: 0.64%
H: 1.11%
C: 0.32%
report year update financial results
Gainers vs Losers
| 75% | 25% |
Top 10 Gainers
AGBA | News | $1.27 217.5% 120M
|
Finance
EGOX | $0.054 50.0% 290M
|
CHRO | $1.66 35.51% 70K
|
n/a
INDO | $5.43 33.09% 10M
|
Energy Minerals
NVFY | $2.71 28.44% 31M
|
Consumer Durables
ZCMD | $1.86 28.28% 29M
|
Commercial Services
RWOD | $10.08 26.05% 5.6M
|
n/a
HUSA 4 | $2.07 23.95% 2.1M
|
Energy Minerals
TPET | $0.4001 22.02% 35M
|
n/a
SRFM 4 | $0.6 21.29% 850K
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.